Sorafenib
targeted anticancer therapy · kinase inhibitor
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Sorafenib belongs to the category “targeted anticancer therapy (kinase inhibitor)”. This targeted therapy attacks a specific mechanism of tumor cells; it falls under a specialized hospital prescription.
In the case of Sorafenib, this means: Treats a cancer by targeting tumour cells. It is part of specialised, closely monitored care.
Under which brands it is found
In France, about 8 reimbursable presentations containing Sorafenib are recorded. It comes under various trade names and in generic form.
- Nexavar
- Sorafenib Accord
- Sorafenib Biogaran
- Sorafenib Eg
- Sorafenib Sandoz
- Sorafenib Teva
- Sorafenib Viatris
- Sorafenib Zentiva
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
Nous n'avançons aucun complément pour Sorafénib : ce serait forcer un besoin qui n'existe pas. La grande majorité des médicaments n'appellent aucune supplémentation particulière, et le reconnaître fait partie de notre manière de travailler. Nous ne concevons un complément que là où les données le soutiennent.
Related molecules
To explore in the « Other areas » family and its neighbours.